论文部分内容阅读
1978年5—9月,我们对10例鼻咽癌患者分阶段选用中草药及环磷酰胺、氨甲喋呤治疗。现将治疗过程中临床表现及免疫功能测定的变化小结于下: 病例的基本情况鼻咽癌患者10例,男性8人,女性2人,年龄25—62岁(平均41岁)。其中,未经放疗或化疗的进展期患者5例,曾接受放疗或/和化疗后复发或可疑复发2例,经放疗或/和化疗后病情暂稳定患者3例。病理分类:鳞癌9例,未分化癌1例。 7例进展期患者临床分期:属于一期1例,二期1例,三期5例。临床TNM分期:T_1NoMo,T_1N_2Mo,T_2NoMo,T_2N_1Mo,T_2N_2Mo,T_3N_1Mo,T_3NoMo各1例。
From May to September of 1978, we selected Chinese herbal medicine, cyclophosphamide, and methotrexate in 10 patients with nasopharyngeal carcinoma. Changes in clinical manifestations and immunological function tests during treatment are summarized below: Cases Basic Cases 10 cases of nasopharyngeal carcinoma, 8 males and 2 females, aged 25-62 years (average 41 years old). Among them, there were 5 patients who had not advanced radiotherapy or chemotherapy, 2 had recurrence or/and relapse after chemotherapy, or 3 patients had temporary stable disease after radiotherapy or/and chemotherapy. Pathological classification: 9 cases of squamous cell carcinoma, 1 case of undifferentiated carcinoma. The clinical stage of 7 patients with advanced stage was: 1 case in 1 case, 1 case in 2nd stage and 5 cases in 3rd stage. Clinical TNM staging: 1 case each of T_1NoMo, T_1N_2Mo, T_2NoMo, T_2N_1Mo, T_2N_2Mo, T_3N_1Mo, and T_3NoMo.